Browse by Section 100 Item List

Highly Specialised Drugs Program (Community Access)

From 1 July 2015, the HSD community access arrangements better align existing HSD programme arrangements with current clinical practice and models of care, through improvements to the way clozapine for the treatment of schizophrenia (maintenance therapy only), HIV antiretroviral medicines and hepatitis B medicines are prescribed, dispensed and accessed under the s100 HSDs Programme.  These changes are known as ‘HSD Community Access’.

These arrangements remove the requirement for patients and prescribers to be affiliated with a hospital setting.  Patients also have greater choice about where they access their medicines, through either a community pharmacy, or a private or public hospital pharmacy.  Community pharmacists are able to dispense these medicines regardless of where the medicine is prescribed.

Prescriptions for these medicines and any repeats from those prescriptions, written prior to 1 July 2015 will need to be dispensed by a hospital pharmacy in accordance with the previous arrangements.

The remuneration rates for Highly Specialised Drugs dispensed through community pharmacies are aligned to those paid to private hospitals.

Patient eligibility criteria are unchanged.  Patients will continue to pay a patient co-payment which will contribute to the PBS Safety Net Record.

Further information on these arrangements is available in the respective Frequently Asked Questions (FAQs).

  • Legend
  • MPMedical Practitioner
  • NPNurse Practitioner
Prescriber code Item code Name, manner of administration and form & strength Max qty
packs
Max qty
units
No. of
repeats
MPNP 11114Y TENOFOVIR ALAFENAMIDE + EMTRICITABINE + ELVITEGRAVIR + COBICISTATtenofovir alafenamide 10 mg + emtricitabine 200 mg + elvitegravir 150 mg + cobicistat 150 mg tablet, 30 2 60 5
MPNP 11142K TENOFOVIR DISOPROXILtenofovir disoproxil phosphate 291 mg tablet, 30 2 60 5
MPNP 11978K TENOFOVIR DISOPROXILtenofovir disoproxil phosphate 291 mg tablet, 30 2 60 2
MPNP 10310P TENOFOVIR DISOPROXILtenofovir disoproxil fumarate 300 mg tablet, 30 2 60 5
MPNP 11992E TENOFOVIR DISOPROXILtenofovir disoproxil fumarate 300 mg tablet, 30 2 60 2
MPNP 11155D TENOFOVIR DISOPROXILtenofovir disoproxil maleate 300 mg tablet, 30 2 60 5
MPNP 11982P TENOFOVIR DISOPROXILtenofovir disoproxil maleate 300 mg tablet, 30 2 60 2
MPNP 12506F TENOFOVIR DISOPROXIL + EMTRICITABINEtenofovir disoproxil succinate 301 mg + emtricitabine 200 mg tablet, 30 2 60 5
MPNP 10347N TENOFOVIR DISOPROXIL + EMTRICITABINEtenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg tablet, 30 2 60 5
MPNP 11149T TENOFOVIR DISOPROXIL + EMTRICITABINEtenofovir disoproxil maleate 300 mg + emtricitabine 200 mg tablet, 30 2 60 5
MPNP 11146P TENOFOVIR DISOPROXIL + EMTRICITABINEtenofovir disoproxil phosphate 291 mg + emtricitabine 200 mg tablet, 30 2 60 5
MPNP 11732L TENOFOVIR DISOPROXIL + EMTRICITABINE + EFAVIRENZtenofovir disoproxil maleate 300 mg + emtricitabine 200 mg + efavirenz 600 mg tablet, 30 2 60 5
MPNP 10344K TIPRANAVIRtipranavir 250 mg capsule, 120 2 240 5